Earnings · China A-shares
Beijing Science Sun Pharmaceutical Co., Ltd. Class A (300485) earnings
Beijing Science Sun Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit -349.61% year on year, +142.31% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -1.16% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -349.61%
- Excl. one-offs YoY
- +142.31%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.80% | — |
| 3 days | -1.16% | — |
| 7 days | +0.51% | — |
| 14 days | -6.29% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +0.37%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | -¥129.45M | -349.61% | +142.31% | -14.95% | -0.27 | -3.93% | -1.16% | — | — |
| 2026 interim report | 2026-08-24 | -¥143.67M | -400.66% | -69.96% | -8.17% | -0.30 | -4.36% | -6.26% | -15.64% | -8.73% |
| 2026 Q1 report | 2026-04-29 | ¥4.66M | -88.33% | +759.26% | -2.27% | 0.01 | 0.14% | -4.80% | -26.07% | -27.01% |
| 2025 annual report | 2026-03-31 | ¥14.57M | +121.16% | — | -2.82% | 0.03 | 0.43% | +7.03% | -7.21% | -15.63% |
| 2025 Q3 report | 2025-10-24 | ¥51.86M | +152.81% | — | -4.41% | 0.11 | 1.53% | +0.67% | -4.58% | -4.36% |
| 2025 interim report | 2025-08-22 | ¥47.79M | +145.45% | -52.21% | -8.40% | 0.10 | 1.41% | +0.07% | -20.65% | -28.44% |
| 2025 Q1 report | 2025-04-24 | ¥39.97M | +120.97% | -92.15% | -15.52% | 0.08 | 1.18% | +2.93% | +62.80% | +60.53% |
| 2024 annual report | 2025-03-29 | -¥68.85M | -166.90% | +127.94% | -12.61% | -0.14 | -2.03% | +4.48% | +11.13% | +12.68% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.